The use of an aromatic substitution reaction in the spectrophotometric determination of selected amino or thiol containing drugs

Journal of Food and Drug Analysis

Volumn 16, Issue 1, 2008, Pages 26-33

  Belal, Saied Fathalla ^a   Haggag, Rim Said ^a   Shaalan, Rasha Abdel Aziz ^a  

^a Alexandria University Faculty of Pharmacy   (Egypt)

Author keywords

Acetylcysteine; Amlodipine besylate; Captopril; Dinitrofluorobenzene; Dosage forms; Heptaminol hydrochloride; Spectrophotometry

Indexed keywords

1 FLUORO 2,4 DINITROBENZENE; ACETYLCYSTEINE; AMINO ACID DERIVATIVE; AMLODIPINE; AMLODIPINE BESYLATE; AMLODIPINE PLUS BENAZEPRIL; AROMATIC COMPOUND; BENAZEPRIL; BUFFER; CAPOTEN TM; CAPTOPRIL; CAPTOPRIL PLUS HYDROCHLOROTHIAZIDE; CORASOR; EXCIPIENT; HEPTAMINOL; HYDROCHLOROTHIAZIDE; RESPIRIN; THIOL DERIVATIVE; UNCLASSIFIED DRUG;

AQUEOUS SOLUTION; ARTICLE; CHEMICAL REACTION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG DOSAGE FORM; DRUG FORMULATION; DRUG STRUCTURE; PROCESS OPTIMIZATION; QUANTITATIVE ANALYSIS; SPECTROPHOTOMETRY; SUBSTITUTION REACTION; THEORETICAL STUDY; VALIDATION PROCESS;

EID: 42249097113     PISSN: 10219498     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Sweetman, S. C. ed. Martindale 2002. The Complete Drug Reference. 33rd ed. pp. 838, 839, 853, 854, 1082, 1083, 1619. The Pharmaceutical Press. London, U. K.
2. Cavrini, V., Gatti, R., Roveri, P. and Cesaroni, M. R. 1988. Use of 4-(6-methyl-2-naphthyl)-4-oxobut-2-enoic acid as a reagent for the spectrophotometric and fluorimetric determination of aliphatic thiol drugs. Analyst 113: 1447-1452.
3. Sanchez-Pedreno, C., Albero, M. I., Garcia, M. S. and Rodenas, V. 1992. Determination of N-acetylcysteine in pharmaceutical samples by flow injection. Analyst 117: 925-928.
4. Imai, K., Toyoka, T. and Watanabe, Y. 1983. Novel fluorogenic reagent for thiols: Ammonium7-fluorobenzofurazan-4-sulphonate. Anal. Biochem. 128: 471-473.
5. Toyo'oka, T., Suzuki, T., Saito, Y., Uzu, S. and Imai, K. 1989. Fluorogenic reagents for thiols: 4-(N,N-dimethyl amino-sulphonyl)-7-fluoro-2,1,3 -benzoxadiazole [7-fluoro-N,N-dimethyl benzofurazan-4-sulphonamide]. Analyst 114: 413-419.
6. Farquhar, J., Finlay, G., Ford, P. A. and Martin-Smith, M. 1985. Reversed- phase high- performance liquid chromatographic assay for the determination of N-acetylcysteine in aqueous formulations. J. Pharm. Biomed. Anal. 3: 279-285.
7. Tsai, F. Y., Chen, C. J. and Chien, C. S. 1995. Determination of the cysteine derivatives N-acetylcysteine, S-carboxymethylcysteine and methyl cysteine in pharmaceuticals by high performance liquid chromatography. J. Chromatogr. A 697: 309-315.
8. Chassaing, C., Gronin, J., Wilcox, C. S. and Wainer, I. W. 1999. Determination of reduced and oxidized homocysteine and related thiols in plasma by thio-specific pre-column derivatization and capillary electrophoresis with lazer-induced fluorescence detection. J. Chromatogr. B Biomed. Appl. 735: 219-227.
9. Belal, F., Metwally, M. E. S. and Moustafa, M. A. 1991. Polarographic determination of N-acetyl-L-cysteine in pharmaceutical preparations. J. Pharm. Belg. 46: 320-324.
10. Yan, J. L., Sun, R. D. and Sun, W. D. 2003. Electrochemical behaviour of N-acetyl-L-cysteine at mercury film electrode. Fenxi-Huaxue 31: 448-450.
11. Kadin, H. 1982. Analytical Profiles of Drug Substances. Vol. 11. pp. 79-137. Florey, K. ed. Academic Press. New York, U. S. A.
12. Emmanuel, J. and Halankar, S. D. 1989. Sensitive spectrocolorimetric method for the estimation of captopril and its formulations. Indian Drugs 26: 319-320.
13. Sastry, C. S. P., Srinivas, K. R. and Prasad, K. M. M. K. 1996. Spectrophotometric determination of bioactive compounds in commercial samples with nitrous acid and cresyl fast violet acetate. Anal. Lett. 29: 1329-1349.
14. Ma, W. X. 1999. A new method for the determination of captopril. Guangpuxue Yu Guangpu Fenxi 19: 118-119.
15. Pimenta, A. M., Araujo, A. N., Conceicao, M. and Montenegro, B. S. M. 2001. Sequential injection analysis of captopril based on colorimetric and potentiometric detection. Anal. Chim. Acta 438: 31-38.
16. Tzanavaras, P. D., Themelis, D. G., Economou, A. and Theodoridis, G. 2002. Reversed flow-injection manifold for the spectrophotometric determination of captopril based on its inhibitory effect on the cobalt (II)-2,2′-dipyridyl-2- pyridylhydrazone complex formation. Talanta 57: 575-581.
17. Segarra Guerrero, R., Sagrado Vives, S. and Martinez Calatayud, J. 1991. Fluorimetric determination of captopril by flow injection analysis. Microchim. J. 43: 176-180.
18. Ghandour, M. A., Aboul-Kasim, E., El-Haty, M. T. and Ahmed, M. M. 2002. Cathodic stripping voltammetry of the antihypertensive drug captopril in both aqueous and biological media. Anal. Lett. 35: 239-256.
19. Ioannides, X., Economou, A. and Voulgaropoulos, A. 2003. A study of the determination of the hypertensive drug captopril by square wave cathodic adsorptive stripping voltammetry. J. Pharm. Biomed. Anal. 33: 309-316.
20. Czerwinska, K., Wyszomirska, E. and Kaniewska, T. 2001. Identification and determination of selected medicines reducing hypertension by densitometric and gas-chromatographic methods. Acta. Pol. Pharm. 58: 331-338.
21. Tache, F., Farca, A., Medvedovici, A. and David, V. 2002. Validation of a LC- fluorescence method for determination of free captopril in human plasma, using a pre-column derivatization reaction with Monobromobimane. J. Pharm. Biomed. Anal. 28: 549-557.
22. Mirza, T. and Tan, H. S. I. 2001. Determination of captopril in pharmaceutical tablets by anion- exchange HPLC using indirect photometric detection; a study in systematic method development. J. Pharm. Biomed. Anal. 25: 39-52.
23. El-Reis, M. A., Abou-Attia, F. M. and Kenawy, I. M. M. 2000. Indirect determination of captopril by AAS. J. Pharm. Biomed. Anal. 23: 249-254.
24. Hillaert, S. and van-den-Bossche, W. 1999. Determination of captopril and its degradation products by capillary electrophoresis. J. Pharm. Biomed. Anal. 21: 65-73.
25. Sridhar, K., Sastry, C. S. P., Reddy, M. N., Sankar, D. G. and Rama-Srinivas, K. 1997. Spectrophotometric determination of amlodipine besylate in pure forms and tablets. Anal. Lett. 30: 121-133.
26. Prabhakar, A. H. and Giridhar, R. 2002. A spectrophotometric method for the determination of amlodipine besylate in pure form and in tablets. Indian Drugs 39: 204-208.
27. Rahman, N. and Azmi, S. N. H. 2000. Spectrophotometric determination of amlodipine besylate by charge-transfer complex formation with p- chloranilic acid. Anal. Sci. 16: 1353-1356.
28. Khopade, S. A. and Jain, N. K. 2000. Difference spectrophotometric estimation of amlodipine besylate. Indian Drugs 37: 351-353.
29. Patki, R. V., Tamhankar, C. P. and Tipnis, H. P. 1994. Simple and rapid high performance liquid chromatographic estimation of amlodipine from pharmaceutical dosages. Indian Drugs 31: 560-561.
30. Chandrashekhar, T. G., Rao, P. S. N., Smrita, K., Vyas, S. K. and Dutt, C. 1994. Analysis of amlodipine besylate by HPTLC with fluorimetric detection: A sensitive method for assay of tablets. J. Planar. Chromatogr. Mod. TLC. 7: 458-460.
31. Gazy, A. A. K. 2004. Determination of amlodipine besylate by adsorptive square wave anodic- stripping voltammetry on glassy carbon electrode in tablets and biological fluids. Talanta 62: 575-582.
32. El-Walily, A. F. M., El-Yazbi, F. A., Belal, S. F. and Abdel-Razak, O. 1997. Spectrophotometric and spectrofluorimetric determination of heptaminol and mexiletine in their dosage forms. Anal. Lett. 30: 2029-2043.
33. Rabouan-Guyon, S., Courtois, P. and Barthes, D. 1996. Determination of heptaminol acephyllinate in pharmaceutical preparations by high-performance liquid chromatography. Farmaco 51: 739-746.
34. Bauer, M., Mailhe, L. and Nguyen, L. 1984. Determination of heptaminol in pharmaceutical preparations by liquid chromatography after derivatization with 4-dimethylaminoazobenzene-4′-isothiocyanate. J. Chromatogr. 292: 468-472.
35. Leroy, P., Nicolas, A. and Moreau, A. 1983. Electrochemical detection of sympathomimetic drugs, following pre- column o-phthalaldehyde derivatization and reversed-phase high performance liquid chromatography. J. Chromatogr. 282: 561-568.
36. Geigy, J. R. and Basle, S. A. 1970. Scientific Documenta Geigy. 7th ed. p. 314. Deim, K. and Lentner, C. ed. Switzerland.
37. Connors, K. A. ed. 1973. Reaction Mechanisms in Organic Analytical Chemistry. p. 274. Wiley, New York, U. S. A.
38. The United States Pharmacopeia, 27th Revision, The National Formulary, 22nd Revision. 2004. pp. 2748-2751. United States Pharmacopeial Convention, Inc. Rockville, MD, U. S. A.
39. British Pharmacopoeia. 2003. vol. III. pp. 2148-2149. Her Majesty's Stationery Office. London, U. K.
40. Patel, Y. P., Patil, S., Bhoir, I. C. and Sundaresan, M. 1998. Isocratic, simultaneous reversed-phase high performance liquid chromatographic estimation of six drugs for combined hypertension therapy. J. Chromatogr. A 828: 283-286.